Reportlinker finds all market research
reports published by official sources!
Company Report: Pathology for Year 2011
- This 3-page company report was published in March 2011.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Pathology Industry : Latest Downloads
Roth Capital Partners L.L.C. - Company Report for Year 2012
- Company report
- December 2012
- 24 pages
Company Report: Pathology for Year 2013
- Company report
- April 2013
- 12 pages
... attack or stroke. Atheronova is also conducting additional academic research, including a study of the effects of ahro 003 Supplementation on atherosclerotic ...
Company Report: Mental Health for Year 2013
- Company report
- April 2013
- 15 pages
... As locally as possible and reducing the need for hospital inpatient care wherever feasible. Acute, intermediate, community and mental health services are delivered across a network of community clinics ...
Company Report: Pathology For Year 2013
2 months agoCompany Report: Pathology For Year 2013
2 months agoCompany Report: Pathology For Year 2013
2 months agoCompany Report: Pathology For Year 2013
2 months agoCompany Report: Pathology For Year 2013
3 months agoCompany Report: Pathology For Year 2013
3 months agoAccountable - Company Report For Year 2013
3 months agoMore Reports:
Pathology in Australia (47)
Pathology in Canada (45)
Pathology in China (14)
Pathology in France (12)
Pathology in Germany (14)
Related Market Segments :
Renal Cancer
Pathology Industry : Latest Reports
Cancer Antibodies: Drug Target Atlas and Competitive Outlook
- $ 3 675
- Company report
- November 2012
- by Bioseeker
Personalized medicine is very much about fitting target profiles of drugs towards disease mechanism(s). This report is a new and unique way of stratifying and analyzing the global antibody pipeline in ...
Therapy in United States: Type 2 Diabetes - Pipeline Review, H1 2012
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Rheumatoid Arthritis - Pipeline Review, H1 2013
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
Rheumatoid Arthritis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rheumatoid Arthritis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
More Reports:
Pathology in Argentina (8)
Pathology in Brazil (23)
Pathology in Canada (53)
Pathology in China (78)
Pathology in France (135)
Pathology in Germany (137)
Related Market Segments :
Renal Cancer
Reportlinker.com © Copyright 2013. All rights reserved.
